Literature DB >> 33328346

Interactions of the Nipah Virus P, V, and W Proteins across the STAT Family of Transcription Factors.

Timothy R Keiffer1, Michael J Ciancanelli2,3, Megan R Edwards1, Christopher F Basler4.   

Abstract

The Nipah virus (NiV) phosphoprotein (P) gene encodes four proteins. Three of these-P, V, and W-possess a common N-terminal domain but distinct C termini. These proteins interact with immune modulators. Previous studies demonstrated that P, V, and W bind STAT1 and STAT4 and that V also interacts with STAT2 but not with STAT3. The STAT1 and STAT2 interactions block interferon (IFN)-induced STAT tyrosine phosphorylation. To more fully characterize the interactions of P, V, and W with the STATs, we screened for interaction of each viral protein with STATs 1 to 6 by coimmunoprecipitation. We demonstrate that NiV P, V, and W interact with STAT4 through their common N-terminal domain and block STAT4 activity, based on a STAT4 response element reporter assay. Although none of the NiV proteins interact with STAT3 or STAT6, NiV V, but not P or W, interacts with STAT5 through its unique C terminus. Furthermore, the interaction of NiV V with STAT5 was not disrupted by overexpression of the N-terminal binding STAT1 or the C-terminal binding MDA5. NiV V also inhibits a STAT5 response element reporter assay. Residues 114 to 140 of the common N-terminal domain of the NiV P gene products were found to be sufficient to bind STAT1 and STAT4. Analysis of STAT1-STAT3 chimeras suggests that the P gene products target the STAT1 SH2 domain. When fused to GST, the 114-140 peptide is sufficient to decrease STAT1 phosphorylation in IFN-β-stimulated cells, suggesting that this peptide could potentially be fused to heterologous proteins to confer inhibition of STAT1- and STAT4-dependent responses.IMPORTANCE How Nipah virus (NiV) antagonizes innate immune responses is incompletely understood. The P gene of NiV encodes the P, V, and W proteins. These proteins have a common N-terminal sequence that is sufficient to bind to STAT1 and STAT2 and block IFN-induced signal transduction. This study sought to more fully understand how P, V, and W engage with the STAT family of transcription factors to influence their functions. The results identify a novel interaction of V with STAT5 and demonstrate V inhibition of STAT5 function. We also demonstrate that the common N-terminal residues 114 to 140 of P, V, and W are critical for inhibition of STAT1 and STAT4 function, map the interaction to the SH2 region of STAT1, and show that a fusion construct with this peptide significantly inhibits cytokine-induced STAT1 phosphorylation. These data clarify how these important virulence factors modulate innate antiviral defenses.
Copyright © 2020 Keiffer et al.

Entities:  

Keywords:  Nipah virus; STAT transcription factors; interferon

Year:  2020        PMID: 33328346      PMCID: PMC7771230          DOI: 10.1128/mSphere.00449-20

Source DB:  PubMed          Journal:  mSphere        ISSN: 2379-5042            Impact factor:   4.389


  76 in total

Review 1.  Nipah and hendra virus interactions with the innate immune system.

Authors:  Christopher F Basler
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

2.  Establishment of a Nipah virus rescue system.

Authors:  Misako Yoneda; Vanessa Guillaume; Fusako Ikeda; Yuki Sakuma; Hiroki Sato; T Fabian Wild; Chieko Kai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

3.  Complete nucleotide sequences of Nipah virus isolates from Malaysia.

Authors:  Y P Chan; K B Chua; C L Koh; M E Lim; S K Lam
Journal:  J Gen Virol       Date:  2001-09       Impact factor: 3.891

4.  Activation and cell death in human dendritic cells infected with Nipah virus.

Authors:  Manisha Gupta; Michael K Lo; Christina F Spiropoulou
Journal:  Virology       Date:  2013-04-13       Impact factor: 3.616

5.  Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism.

Authors:  Michael J Ciancanelli; Valentina A Volchkova; Megan L Shaw; Viktor E Volchkov; Christopher F Basler
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

6.  Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets.

Authors:  Benjamin A Satterfield; Robert W Cross; Karla A Fenton; Viktoriya Borisevich; Krystle N Agans; Daniel J Deer; Jessica Graber; Christopher F Basler; Thomas W Geisbert; Chad E Mire
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

7.  STAT protein interference and suppression of cytokine signal transduction by measles virus V protein.

Authors:  Heidi Palosaari; Jean-Patrick Parisien; Jason J Rodriguez; Christina M Ulane; Curt M Horvath
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  Identifying Early Target Cells of Nipah Virus Infection in Syrian Hamsters.

Authors:  Laura Baseler; Dana P Scott; Greg Saturday; Eva Horne; Rebecca Rosenke; Tina Thomas; Kimberly Meade-White; Elaine Haddock; Heinz Feldmann; Emmie de Wit
Journal:  PLoS Negl Trop Dis       Date:  2016-11-03

Review 9.  Nipah virus infection: A review.

Authors:  M Shariff
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

10.  Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways.

Authors:  Megan L Shaw; Washington B Cardenas; Dmitriy Zamarin; Peter Palese; Christopher F Basler
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

View more
  9 in total

Review 1.  The Immunobiology of Nipah Virus.

Authors:  Yvonne Jing Mei Liew; Puteri Ainaa S Ibrahim; Hui Ming Ong; Chee Ning Chong; Chong Tin Tan; Jie Ping Schee; Raúl Gómez Román; Neil George Cherian; Won Fen Wong; Li-Yen Chang
Journal:  Microorganisms       Date:  2022-06-06

Review 2.  Mechanisms of Viral Degradation of Cellular Signal Transducer and Activator of Transcription 2.

Authors:  Sailen Barik
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

3.  Nipah virus W protein harnesses nuclear 14-3-3 to inhibit NF-κB-induced proinflammatory response.

Authors:  François Enchéry; Claire Dumont; Mathieu Iampietro; Rodolphe Pelissier; Denis Gerlier; Noémie Aurine; Louis-Marie Bloyet; Caroline Carbonnelle; Cyrille Mathieu; Chloé Journo; Branka Horvat
Journal:  Commun Biol       Date:  2021-11-16

Review 4.  Evasion of Host Antiviral Innate Immunity by Paramyxovirus Accessory Proteins.

Authors:  Chongyang Wang; Ting Wang; Liuyuan Duan; Hui Chen; Ruochen Hu; Xiangwei Wang; Yanqing Jia; Zhili Chu; Haijin Liu; Xinglong Wang; Shuxia Zhang; Sa Xiao; Juan Wang; Ruyi Dang; Zengqi Yang
Journal:  Front Microbiol       Date:  2022-01-31       Impact factor: 5.640

5.  Poxviruses and paramyxoviruses use a conserved mechanism of STAT1 antagonism to inhibit interferon signaling.

Authors:  Callum Talbot-Cooper; Teodors Pantelejevs; John P Shannon; Christian R Cherry; Marcus T Au; Marko Hyvönen; Heather D Hickman; Geoffrey L Smith
Journal:  Cell Host Microbe       Date:  2022-02-18       Impact factor: 21.023

Review 6.  Evolutionary history of cotranscriptional editing in the paramyxoviral phosphoprotein gene.

Authors:  Jordan Douglas; Alexei J Drummond; Richard L Kingston
Journal:  Virus Evol       Date:  2021-03-27

7.  Experimental Evidence of Intrinsic Disorder and Amyloid Formation by the Henipavirus W Proteins.

Authors:  Giulia Pesce; Frank Gondelaud; Denis Ptchelkine; Juliet F Nilsson; Christophe Bignon; Jérémy Cartalas; Patrick Fourquet; Sonia Longhi
Journal:  Int J Mol Sci       Date:  2022-01-15       Impact factor: 5.923

8.  Identification of a Region in the Common Amino-terminal Domain of Hendra Virus P, V, and W Proteins Responsible for Phase Transition and Amyloid Formation.

Authors:  Edoardo Salladini; Frank Gondelaud; Juliet F Nilsson; Giulia Pesce; Christophe Bignon; Maria Grazia Murrali; Roxane Fabre; Roberta Pierattelli; Andrey V Kajava; Branka Horvat; Denis Gerlier; Cyrille Mathieu; Sonia Longhi
Journal:  Biomolecules       Date:  2021-09-07

9.  Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine.

Authors:  Rebecca J Loomis; Anthony T DiPiazza; Samantha Falcone; Tracy J Ruckwardt; Kaitlyn M Morabito; Olubukola M Abiona; Lauren A Chang; Ria T Caringal; Vladimir Presnyak; Elisabeth Narayanan; Yaroslav Tsybovsky; Deepika Nair; Geoffrey B Hutchinson; Guillaume B E Stewart-Jones; Lisa A Kueltzo; Sunny Himansu; John R Mascola; Andrea Carfi; Barney S Graham
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.